KTN3379

KTN3379 · Celldex Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KTN3379, covering 2017-07-24 to 2017-07-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced Tumors [Phase 1]

See pricing